USPTO serial 99007567
XTURNPOINT
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- CERDA, VICTOR
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with XTURNPOINT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $772*
Plus Government fees of $375
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chicago, IL, US
Chicago, IL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eric R. Moran
Eric R. Moran McDonnell Boehnen Hulbert & Berghoff LLP300 South Wacker Drive31st FloorChicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics | ACTIVE | — |
| 036 | Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics | ACTIVE | — |
| 042 | Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 7, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 7, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 7, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 7, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 7, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 12, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 12, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 6, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 8, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 8, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 8, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 8, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 8, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 27, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 17, 2025 | NWAP | NEW APPLICATION ENTERED | — |